Your browser doesn't support javascript.
loading
BAX -248 G>A and BCL2 -938 C>A Variant Lowers the Survival in Patients with Nasopharyngeal Carcinoma and Could be Associated with Tissue-Specific Malignancies: A Multi-Method Approach.
Chatterjee, Koustav; De, Saikat; Deb Roy, Sankar; Sahu, Sushil Kumar; Chakraborty, Arindom; Ghatak, Sandeep; Das, Nilanjana; Mal, Sudipa; Roy Chattopadhyay, Nabanita; Das, Piyanki; Reddy, R Rajendra; Mukherjee, Syamantak; Das, Ashok Kumar; Puii, Zoreng; Zomawia, Eric; Singh, Yengkhom Indibor; Tsering, Sam; Riba, Komri; Rajasubramaniam, Shanmugam; Suryawanshi, Amol Ratnakar; Choudhuri, Tathagata.
Afiliação
  • Chatterjee K; Department of Biotechnology, Visva-Bharati, Santiniketan, Birbhum, West Bengal, India.
  • De S; Department of Biotechnology, Visva-Bharati, Santiniketan, Birbhum, West Bengal, India.
  • Deb Roy S; Department of Radiation Oncology, Eden Medical Centre, Dimapur, Nagaland, India.
  • Sahu SK; Department of Pharmacology and Molecular Sciences, School of Medicine, Johns Hopkins University, Baltimore, Maryland, United States.
  • Chakraborty A; Department of Statistics, Visva-Bharati, Santiniketan, West Bengal, India.
  • Ghatak S; Division of Animal and Fishery Science, ICAR Research Complex for North East Hill Region,Umiam, Meghalaya, India.
  • Das N; Department of Biotechnology, Visva-Bharati, Santiniketan, Birbhum, West Bengal, India.
  • Mal S; Department of Biotechnology, Visva-Bharati, Santiniketan, Birbhum, West Bengal, India.
  • Roy Chattopadhyay N; Department of Biotechnology, Visva-Bharati, Santiniketan, Birbhum, West Bengal, India.
  • Das P; Department of Biotechnology, Visva-Bharati, Santiniketan, Birbhum, West Bengal, India.
  • Reddy RR; Clinical Proteomics, Institute of Life Sciences, Bhubaneswar, India.
  • Mukherjee S; Department of Biotechnology, Visva-Bharati, Santiniketan, Birbhum, West Bengal, India.
  • Das AK; Department of ENT, Dr B. Borooah Cancer Institute, Guwahati, Assam, India.
  • Puii Z; State Referral Hospital, Falkawn, Mizoram, India.
  • Zomawia E; State Referral Hospital, Falkawn, Mizoram, India.
  • Singh YI; Regional Institute of Medical Sciences, Department of Radiotherapy, Imphal, Manipur, India.
  • Tsering S; Tertiary cancer center,TomoRiba Institute of Health And Medical Sciences, Arunachal Pradesh, India.
  • Riba K; Tertiary cancer center,TomoRiba Institute of Health And Medical Sciences, Arunachal Pradesh, India.
  • Rajasubramaniam S; Division of Genetic Disorders ICMR-National Institute of Research in Tribal Health, NIRTH Complex, Jabalpur, Madhya Pradesh, India.
  • Suryawanshi AR; Clinical Proteomics, Institute of Life Sciences, Bhubaneswar, India.
  • Choudhuri T; Department of Biotechnology, Visva-Bharati, Santiniketan, Birbhum, West Bengal, India.
Asian Pac J Cancer Prev ; 22(4): 1171-1181, 2021 Apr 01.
Article em En | MEDLINE | ID: mdl-33906310
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Nasofaríngeas / Proteínas Proto-Oncogênicas c-bcl-2 / Proteína X Associada a bcl-2 / Carcinoma Nasofaríngeo Idioma: En Ano de publicação: 2021 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Nasofaríngeas / Proteínas Proto-Oncogênicas c-bcl-2 / Proteína X Associada a bcl-2 / Carcinoma Nasofaríngeo Idioma: En Ano de publicação: 2021 Tipo de documento: Article